Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility

Betti Giusti, Anna Maria Gori, Rossella Marcucci, Ilaria Sestini, Claudia Saracini, Elena Sticchi, Francesca Gensini, Cinzia Fatini, Rosanna Abbate, Gian Franco Gensini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background:Hyperhomocysteinemia has been suggested to play a role in the NonValvular Atrial Fibrillation (NVAF) pathogenesis. Polymorphisms in genes coding for homocysteine (Hcy) metabolism enzymes may be associated with hyperhomocysteinemia and NVAF.Methodologies:456 NVAF patients and 912 matched controls were genotyped by an electronic microchip technology for C677T and A1298C MTHFR, A2756G MTR, and -786C/T eNOS gene polymorphisms. Hcy was determined by an immunoassay method.Principal Findings:The genotype distribution of the four polymorphisms as well as genotype combinations did not differ in patients and controls. Hcy was higher in patients than in controls (15.2, 95%CI 14.7-15.7 vs 11.3, 95%CI 11.0-11.6 μmol/L; p

Original languageEnglish
Article numbere495
JournalPLoS One
Volume2
Issue number6
DOIs
Publication statusPublished - 2007

Fingerprint

homocysteine
Homocysteine
Polymorphism
Atrial Fibrillation
Hyperhomocysteinemia
Genes
genetic polymorphism
Genotype
genes
genotype
immunoassays
Immunoassay
Metabolism
electronics
pathogenesis
Technology
metabolism
Enzymes
enzymes
methodology

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Giusti, B., Gori, A. M., Marcucci, R., Sestini, I., Saracini, C., Sticchi, E., ... Gensini, G. F. (2007). Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility. PLoS One, 2(6), [e495]. https://doi.org/10.1371/journal.pone.0000495

Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility. / Giusti, Betti; Gori, Anna Maria; Marcucci, Rossella; Sestini, Ilaria; Saracini, Claudia; Sticchi, Elena; Gensini, Francesca; Fatini, Cinzia; Abbate, Rosanna; Gensini, Gian Franco.

In: PLoS One, Vol. 2, No. 6, e495, 2007.

Research output: Contribution to journalArticle

Giusti, B, Gori, AM, Marcucci, R, Sestini, I, Saracini, C, Sticchi, E, Gensini, F, Fatini, C, Abbate, R & Gensini, GF 2007, 'Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility', PLoS One, vol. 2, no. 6, e495. https://doi.org/10.1371/journal.pone.0000495
Giusti, Betti ; Gori, Anna Maria ; Marcucci, Rossella ; Sestini, Ilaria ; Saracini, Claudia ; Sticchi, Elena ; Gensini, Francesca ; Fatini, Cinzia ; Abbate, Rosanna ; Gensini, Gian Franco. / Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility. In: PLoS One. 2007 ; Vol. 2, No. 6.
@article{e05f9cf570a74e0398c4146bda7faeff,
title = "Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility",
abstract = "Background:Hyperhomocysteinemia has been suggested to play a role in the NonValvular Atrial Fibrillation (NVAF) pathogenesis. Polymorphisms in genes coding for homocysteine (Hcy) metabolism enzymes may be associated with hyperhomocysteinemia and NVAF.Methodologies:456 NVAF patients and 912 matched controls were genotyped by an electronic microchip technology for C677T and A1298C MTHFR, A2756G MTR, and -786C/T eNOS gene polymorphisms. Hcy was determined by an immunoassay method.Principal Findings:The genotype distribution of the four polymorphisms as well as genotype combinations did not differ in patients and controls. Hcy was higher in patients than in controls (15.2, 95{\%}CI 14.7-15.7 vs 11.3, 95{\%}CI 11.0-11.6 μmol/L; p",
author = "Betti Giusti and Gori, {Anna Maria} and Rossella Marcucci and Ilaria Sestini and Claudia Saracini and Elena Sticchi and Francesca Gensini and Cinzia Fatini and Rosanna Abbate and Gensini, {Gian Franco}",
year = "2007",
doi = "10.1371/journal.pone.0000495",
language = "English",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility

AU - Giusti, Betti

AU - Gori, Anna Maria

AU - Marcucci, Rossella

AU - Sestini, Ilaria

AU - Saracini, Claudia

AU - Sticchi, Elena

AU - Gensini, Francesca

AU - Fatini, Cinzia

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

PY - 2007

Y1 - 2007

N2 - Background:Hyperhomocysteinemia has been suggested to play a role in the NonValvular Atrial Fibrillation (NVAF) pathogenesis. Polymorphisms in genes coding for homocysteine (Hcy) metabolism enzymes may be associated with hyperhomocysteinemia and NVAF.Methodologies:456 NVAF patients and 912 matched controls were genotyped by an electronic microchip technology for C677T and A1298C MTHFR, A2756G MTR, and -786C/T eNOS gene polymorphisms. Hcy was determined by an immunoassay method.Principal Findings:The genotype distribution of the four polymorphisms as well as genotype combinations did not differ in patients and controls. Hcy was higher in patients than in controls (15.2, 95%CI 14.7-15.7 vs 11.3, 95%CI 11.0-11.6 μmol/L; p

AB - Background:Hyperhomocysteinemia has been suggested to play a role in the NonValvular Atrial Fibrillation (NVAF) pathogenesis. Polymorphisms in genes coding for homocysteine (Hcy) metabolism enzymes may be associated with hyperhomocysteinemia and NVAF.Methodologies:456 NVAF patients and 912 matched controls were genotyped by an electronic microchip technology for C677T and A1298C MTHFR, A2756G MTR, and -786C/T eNOS gene polymorphisms. Hcy was determined by an immunoassay method.Principal Findings:The genotype distribution of the four polymorphisms as well as genotype combinations did not differ in patients and controls. Hcy was higher in patients than in controls (15.2, 95%CI 14.7-15.7 vs 11.3, 95%CI 11.0-11.6 μmol/L; p

UR - http://www.scopus.com/inward/record.url?scp=77951649037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951649037&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0000495

DO - 10.1371/journal.pone.0000495

M3 - Article

C2 - 17551576

AN - SCOPUS:77951649037

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e495

ER -